Shock Syndromes I
Puskarich MA, Trzeciak S, Shapiro NI, et al. Prognostic
value and agreement of achieving lactate clearance or
central venous oxygen saturation goals during early sep-
sis resuscitation. Acad Emerg Med. 2012;19(3):252-258.
https://doi.org/10.1111/j.1553-2712.2012.01292.x
Teboul JL, Hamzaoui O, Monnet X. SvO2 to monitor
resuscitation of septic patients: let’s just understand the
org/10.1186/cc10491
Vignon P, Repessé X, Bégot E, et al. Comparison of
echocardiographic indices used to predict fluid respon-
Med.
2017;195(8):1022-1032.
https://doi.org/10.1164/
rccm.201604-0844oc
Vincent JL, Weil MH. Fluid challenge revisited.
org/10.1097/01.ccm.0000214677.76535.a5
Walley KR. Use of central venous oxygen satu-
Med.
2011;184(5):514-520.
https://doi.org/10.1164/
rccm.201010-1584ci
Zhang Z, Ni H, Qian Z. Effectiveness of treatment
based on PiCCO parameters in critically ill patients
with septic shock and/or acute respiratory distress
syndrome: a randomized controlled trial. Intensive
s00134-014-3638-4
Agents Used to Treat Shock—Fluids and Vasoactive
Agents
Annane D, Siami S, Jaber S, et al. Effects of fluid resuscita-
tion with colloids vs crystalloids on mortality in critically
ill patients presenting with hypovolemic shock: the
1817. https://doi.org/10.1001/jama.2013.280502
Antonucci E, Gleeson PJ, Annoni F, et al. Angiotensin
II in refractory septic shock. Shock. 2017;47(5):560-566.
https://doi.org/10.1097/shk.0000000000000807
Bangash MN, Kong ML, Pearse RM. Use of inotro-
pes and vasopressor agents in critically ill patients.
Br J Pharmacol. 2012;165(7):2015-2033. https://doi.
org/10.1111/j.1476-5381.2011.01588.x
Chawla LS, Busse L, Brasha-Mitchell E, et al. Intravenous
angiotensin II for the treatment of high-output shock
https://doi.org/10.1186/s13054-014-0534-9
De Backer D, Biston P, Devriendt J, et al. Comparison
of dopamine and norepinephrine in the treatment of
shock. N Engl J Med. 2010;362(9):779-789. https://doi.
org/10.1056/nejmoa0907118
Finfer S, Bellomo R, Boyce N, et al. A comparison of
albumin and saline for fluid resuscitation in the inten-
sive care unit. N Engl J Med. 2004;350(22):2247-2256.
https://doi.org/10.1056/nejmoa040232
Finfer S, Micallef S, Hammond N, et al. Balanced
multielectrolyte solution versus saline in critically ill
adults. N Engl J Med. 2022;386(9):815-826. https://doi.
org/10.1056/nejmoa2114464
Gordon AC, Perkins GD, Singer M, et al. Levosimendan
for the prevention of acute organ dysfunction in sep-
sis. N Engl J Med. 2016;375(17):1638-1648. https://doi.
org/10.1056/nejmoa1609409
Guidet B, Soni N, Della Rocca G, et al. A balanced view
doi.org/10.1186/cc9230
Hammond NE, Taylor C, Saxena M, et al. Resuscitation
fluid use in Australian and New Zealand intensive
Med.
2015;41(9):1611-1619.
https://doi.org/10.1007/
s00134-015-3878-y
Hammond NE, Zampieri FG, Di Tanna GL, et al.
Balanced crystalloids versus saline in critically ill
Evid. 2022;1(2):EVIDoa2100010. https://doi.org/10.1056/
evidoa2100010
Havel C, Arrich J, Losert H, Gamper G, Müllner
M, Herkner H. Vasopressors for hypotensive shock.
Cochrane Database Syst Rev. 2011;(5):CD003709.
https://doi.org/10.1002/14651858.cd003709.pub3
Hollenberg SM. Vasoactive drugs in circulatory shock.
doi.org/10.1164/rccm.201006-0972ci
Khanna A, English SW, Wang XS, et al. Angiotensin
II for the treatment of vasodilatory shock. N Engl J
Med.
2017;377(5):419-430.
https://doi.org/10.1056/
nejmoa1704154
Landoni G, Lomivorotov VV, Alvaro G, et al.
Levosimendan for hemodynamic support after cardiac
surgery. N Engl J Med. 2017;376(21):2021-2031. https://
doi.org/10.1056/nejmoa1616325